Bioprocessing Solutions & Products for Vaccines
Vaccine concepts were developed to target infectious diseases but are now also focusing on immune-oncology applications. That is leading to the growing use of processing applications using primary cells or cell lines.
Avantor® combines our in-depth understanding of how various chemistries perform in cell culture systems with our portfolio of chemicals for biopharmaceutical production, single-use systems, process chromatography media, and final fill products to sustain the integrity and activity of the vaccine manufacturing process from upstream production or cell-free synthesis to downstream purification process steps through final fill.
Vaccine manufacturing: COVID-19 and beyond
In this interview, Nandu Deorkar, Vice President of R&D, Biopharma Production at Avantor, shares lessons we can learn from the industry’s historic ramp-up from research to manufacturing.
mRNA vaccines & therapies – Bioprocessing solutions for the mRNA revolution
Avantor offers solutions for every stage of the mRNA vaccine and therapy manufacturing workflow. Partner with Avantor to support your speed to market.
PUPSIT: Exceeding expectations is the standard, not the exception
Avantor uses PUPSIT globally to reduce filter defects and contamination. We go beyond compliance in every detail, every day.
Vaccines Workflows
Avantor Vaccine Manufacturing Solutions
Develop and scale up your vaccines more efficiently with trusted cGMP chemicals and single-use solutions. Our Bioprocessing Solutions team can help! We offer upstream support for all areas including cell culture, cell banking, and onsite media/buffer preparation. We can reduce the burden of routine tasks and improve the productivity of your cell therapy efforts.
Ready to Get Started?
Ready to Maximize Production Efficiency?
Our Bioprocessing Solutions team can help you streamline your biomanufacturing processes!